Quantcast

American Peptide Company is a Gold Sponsor at the American Peptide Symposium

June 25, 2011

American Peptide Company, a leading innovator in peptide manufacturing and peptide-based services, is a Gold Sponsor at the 22nd American Peptide Symposium which will be held on June 25-30, 2011 at the Sheraton Hotel and Marina in San Diego, California.

Sunnyvale, CA (PRWEB) June 24, 2011

American Peptide Company, a leading innovator in peptide manufacturing and peptide-based services, is a Gold Sponsor at the 22nd American Peptide Symposium which will be held on June 25-30, 2011 at the Sheraton Hotel and Marina in San Diego, California.

Visit American Peptide Company at booths 8 and 9 to learn more about their extensive peptide synthesis capabilities and the expansion of their cGMP manufacturing facility located nearby in Vista, California.

The Symposium will bring together investigators of varying backgrounds, with the goal of stimulating discussion, and catalyzing multidisciplinary collaborations in order to push the frontiers of peptide science.

American Peptide Company is providing the speaker’s gifts for the esteemed lecturers of the symposium. The speakers will receive a bottle of wine specially selected from the cellars of Ridge Vineyards.

“We are excited to exhibit at the American Peptide Symposium and pleased to be a Gold Sponsor,” John McKinley said. “American Peptide Company strives to support the peptide community with the highest quality peptide synthesis services and technical expertise.”

About American Peptide Company, Inc.

American Peptide Company (APC) is a leading manufacturer of peptides and peptide conjugates. The company offers comprehensive selections of pre-manufactured catalog peptides, custom synthesis, and GMP peptide active pharmaceutical ingredients (APIs). Our California based manufacturing facilities offer synthesis services under Non GMP (Sunnyvale, California) and cGMP (Vista, California) conditions. Our cGMP manufacturing is performed under strict adherence to FDA Regulations 21 CFR parts 210, 211 and ICH Guidance Q7A. Our Total Peptide Management services support clients in the drug development process from pre-clinical thru commercial stage. Our value added services include process development, scale up production, analytical/process validation, stability studies, CMC, DMF, and regulatory support.

APC is proficient in solid-phase and solution-phase peptide synthesis, as well as organic conjugations, proteins and PEGylation. As a wholly-owned subsidiary of ILS, Inc., a member of Otsuka group of Japan. APC has offices in the U.S. and representatives in Japan, South Korea, the UK, and China. APC remains dedicated to delivering high quality peptides to pharmaceutical and biotech companies worldwide. For more information, please visit http://www.americanpeptide.com.

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/6/prweb8598197.htm


Source: prweb



comments powered by Disqus